Clinical Trials Sponsored by Ciro Caruso

Total 5275 results

Ciro Caruso

Completed

Topo-pachimetric Accelerated Epi-On Cross-linking Compared to Dresden Protocol Using Riboflavin With Vitamin E TPGS

Keratoconus

Italy
Thomas Caruso

Recruiting

Virtual Reality as a Self-Efficacy Intervention

Psychological

United States
Thomas Caruso

Enrolling by invitation

Prehospital Provider Training With Augmented Reality (AR)

Hypoglycemia | Pediatric ALL

United States
Salvatore Caruso

Unknown

Vaginal Estriol Before and Vaginal Surgery for Prolapse (VSaE)

Genital Prolapse
Maruho Europe Limited
Maruho Co., Ltd.

Completed

Efficacy Study Comparing Topical M518101 and Vitamin D3 in Adult Psoriasis Patients

Plaque Psoriasis

Germany, Austria, Bulgaria, Hungary, Lithuania, Poland
Caerus Corporation

Enrolling by invitation

Study to Evaluate the OrthoCor Active System for Pain Relief

Pain

United States
University Hospital Carl Gustav Carus

Terminated

Standard vs. Reduced-Intensity Conditioning in Patients With Acute Myeloid Leukemia in First Remission

Acute Myeloid Leukemia

Germany
University Hospital Carl Gustav Carus

Unknown

Gemtuzumab Ozogamicin Before Allogeneic Stem Cell Transplantation

Acute Myeloid Leukemia | Allogeneic Transplantation

Germany
University Hospital Carl Gustav Carus

Completed

Automated Early Warning Scoring on Surgical Normal Wards

Emergencies | Safety Issues

Germany
University Hospital Carl Gustav Carus

Completed

Prophylactic Transfer of Leukemia-reactive T Cells After Allogeneic Transplantation

Chronic Myeloid Leukemia

Germany
University Hospital Carl Gustav Carus

Completed

Early Allogeneic Blood Stem Cell Transplantation in High-risk Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia

Germany
University Hospital Carl Gustav Carus

Completed

Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma

Multiple Myeloma | Plasmocytoma

Germany
Cardio Surgical Partners

Recruiting

Multicenter Outcome Registry of AnaLgesic Effect of SCS(MORALES) Registry Protocol

SCS

United States
Maruho Co., Ltd.

Active, not recruiting

An Open-label, Phase 2 Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Systemic Sclerosis

Systemic Sclerosis

Japan
Maruho Co., Ltd.

Withdrawn

A Phase 2, Multicenter, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pefcalcitol Ointment, 0.005%, Applied Topically Twice Daily (BID) for 8 Weeks in Adolescent Subjects 12 to < 17 Years of Age With Plaque Psoriasis

Psoriasis
Maruho Co., Ltd.

Completed

Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle

Rosacea

United States, France, United Kingdom, Germany, Australia, Canada, New Zealand, Netherlands, Sweden
Martín, Carlos García

Completed

Upper Cross Syndrome Rehabilitation Strengthening of the Dorsal Erector Muscles

Neck Pain

Spain
Clarus Therapeutics, Inc.

Completed

Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men

Male Hypogonadism

United States, Germany
Clarus Therapeutics, Inc.

Completed

Pharmacokinetic Study to Determine Time to Steady-state

Male Hypogonadism | Secondary Hypogonadism | Primary Hypogonadism

United States
4Tech Cardio Ltd.

Terminated

Early Feasibility Study of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System

Heart Valve Diseases | Tricuspid Valve Insufficiency | Functional Tricuspid Regurgitation

United States
4Tech Cardio Ltd.

Terminated

Clinical Trial Evaluation of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System

Tricuspid Regurgitation

Netherlands, Australia, United Kingdom, France, Denmark, Belgium, Germany
Maruho Europe Limited

Completed

Drug-Drug Interaction Study: ASP2151 and Midazolam

Healthy

United Kingdom
Clarus Therapeutics, Inc.

Completed

Phlebotomy Study of Testosterone Undecanoate

Hypogonadism

United States
Maruho Co., Ltd.

Completed

A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts.

Cutaneous Warts

Netherlands
Maruho Co., Ltd.

Completed

Phase III Study of ASP2151 in Herpes Simplex Patients

Herpes Simplex

Japan
Maruho Co., Ltd.

Completed

A 21 Day Pharmacokinetics Study in Papulopustular Rosacea

Papulopustular Rosacea

United States
Maruho Co., Ltd.

Completed

Dose-Finding Study of M516102 in the Treatment of Pruritus Associated With Atopic Dermatitis

Atopic Dermatitis

France, Germany, Poland, United Kingdom
Carlos Simon Foundation

Recruiting

Molecular Study of the Maternal-fetal Interface in Preeclampsia. (PREMAFE)

Preeclampsia

Spain
Maruho Co., Ltd.

Completed

Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle

Rosacea

United States, France, United Kingdom, Germany, Canada, Netherlands, New Zealand, Australia, Sweden
Clarus Therapeutics, Inc.

Completed

Study to Determine the Effect of Food on the Absorption of an Oral Testosterone Undecanoate Formulation

Male Hypogonadism

United States, Canada
Maruho Europe Limited

Completed

Drug-Drug Interaction Study: ASP2151 and Ciclosporin

Healthy

United Kingdom
Maruho Co., Ltd.

Unknown

Topical Ionic Contra-Viral Therapy in Actinic Keratosis

Actinic Keratosis

Netherlands
Maruho Europe Limited

Completed

Drug-Drug Interaction Study: ASP2151 and Montelukast

Healthy

United Kingdom
Maruho Europe Limited

Completed

Drug-Drug Interaction Study: ASP2151 and Ritonavir

Healthy

United Kingdom
Maruho Europe Limited

Completed

Drug-Drug Interaction Study: ASP2151 and Bupropion

Healthy

United Kingdom
Maruho Co., Ltd.

Completed

Pharmacodynamics of Omiganan BID in Patients With Atopic Dermatitis

Atopic Dermatitis

Netherlands
Maruho Co., Ltd.

Completed

Pharmacodynamics, Safety/Tolerability and Efficacy of Topical Omiganan in Patients With uVIN

Usual Type Vulval Intraepithelial Neoplasia (uVIN)

Netherlands
Maruho Co., Ltd.

Completed

A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris

Acne Vulgaris

United States
Maruho Co., Ltd.

Completed

Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris

Acne Vulgaris

United States
Maruho Co., Ltd.

Completed

First-in-Human Study of CLS003 ICVT in Subjects With Cutaneous Warts

Cutaneous Warts

Netherlands
Maruho Co., Ltd.

Completed

A Study to Evaluate the Safety and Efficacy of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts

Cutaneous Common Warts

United States
Maruho Co., Ltd.

Completed

A Phase 3 Study to Evaluate the Efficacy and Safety of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts

Cutaneous Common Warts

United States
Maruho Co., Ltd.

Completed

Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel

Rosacea

United States, United Kingdom, Canada, New Zealand, Australia, France, Sweden, Netherlands
Maruho Co., Ltd.

Unknown

Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis

Seborrheic Dermatitis

Netherlands
Maruho Co., Ltd.

Terminated

ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients

HPV-Induced Genital Lesions

Netherlands
Maruho Co., Ltd.

Completed

Phase III Study of ASP2151 in Herpes Zoster Patients

Herpes Zoster

Japan
4Tech Cardio Ltd.

Completed

Percutaneous Treatment of Tricuspid Valve Regurgitation With the TriCinch System™ (PREVENT)

Tricuspid Regurgitation

Germany, France, Italy, Netherlands
Maruho Co., Ltd.

Completed

Topical Challenge With Omiganan and Imiquimod in Healthy Volunteers

Healthy

Netherlands
Maruho Co., Ltd.

Completed

Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic Dermatitis

Atopic Dermatitis

Netherlands
Maruho Co., Ltd.

Completed

Open-label Study of ASP2151 in Herpes Simplex Patients

Herpes Simplex

Japan

3

Subscribe